União Europeia -
islandês -
EMA (European Medicines Agency)
vanflyta
daiichi sankyo europe gmbh - quizartinib dihydrochloride - kyrningahvítblæði, mergbólga - antineoplastic agents, protein kinase inhibitors - vanflyta is indicated in combination with standard cytarabine and anthracycline induction and standard cytarabine consolidation chemotherapy, followed by vanflyta single-agent maintenance therapy for adult patients with newly diagnosed acute myeloid leukaemia (aml) that is flt3-itd positive.
Islândia -
islandês -
LYFJASTOFNUN (Icelandic Medicines Agency)
haldol depot stungulyf, lausn 100 mg/ml
essential pharma limited - haloperidolum dekanóat - stungulyf, lausn - 100 mg/ml
Islândia -
islandês -
LYFJASTOFNUN (Icelandic Medicines Agency)
haldol tafla 1 mg
essential pharma limited - haloperidolum inn - tafla - 1 mg
Islândia -
islandês -
LYFJASTOFNUN (Icelandic Medicines Agency)
haldol stungulyf, lausn 5 mg/ml
essential pharma limited - haloperidolum inn - stungulyf, lausn - 5 mg/ml
Islândia -
islandês -
LYFJASTOFNUN (Icelandic Medicines Agency)
flixotide (flixotide diskos) innöndunarduft 100 míkróg/skammt
glaxosmithkline pharma a/s - fluticasonum própíónat - innöndunarduft - 100 míkróg/skammt
Islândia -
islandês -
LYFJASTOFNUN (Icelandic Medicines Agency)
flixotide (flixotide diskos) innöndunarduft 250 míkróg/skammt
glaxosmithkline pharma a/s - fluticasonum própíónat - innöndunarduft - 250 míkróg/skammt
Islândia -
islandês -
LYFJASTOFNUN (Icelandic Medicines Agency)
flixotide (flixotide diskos) innöndunarduft 500 míkróg/skammt
glaxosmithkline pharma a/s* - fluticasonum própíónat - innöndunarduft - 500 míkróg/skammt
Islândia -
islandês -
LYFJASTOFNUN (Icelandic Medicines Agency)
seretide innöndunarduft, afmældir skammtar 50/100 míkróg/skammt
glaxosmithkline pharma a/s - salmeterolum xínafóat; fluticasonum própíónat - innöndunarduft, afmældir skammtar - 50/100 míkróg/skammt
Islândia -
islandês -
LYFJASTOFNUN (Icelandic Medicines Agency)
seretide innöndunarduft, afmældir skammtar 50/250 míkróg/skammt
glaxosmithkline pharma a/s - fluticasonum própíónat; salmeterolum xínafóat - innöndunarduft, afmældir skammtar - 50/250 míkróg/skammt
Islândia -
islandês -
LYFJASTOFNUN (Icelandic Medicines Agency)
seretide innöndunarduft, afmældir skammtar 50/500 míkróg/skammt
glaxosmithkline pharma a/s - fluticasonum própíónat; salmeterolum xínafóat - innöndunarduft, afmældir skammtar - 50/500 míkróg/skammt